Clinical characteristics and cerebro-spinal fluid cytokine changes in patients with acquired immunodeficiency syndrome and central nervous system infection

Chen,Zhong; Wang,Ning; Huang,Yaxiong; Wang,Min

doi:10.3892/etm.2019.7587

Clinical characteristics and cerebro-spinal fluid cytokine changes in patients with acquired immunodeficiency syndrome and central nervous system infection

Authors:
- Zhong Chen
- Ning Wang
- Yaxiong Huang
- Min Wang
View Affiliations

Affiliations: Department of Acquired Immunodeficiency Syndrome, The First Hospital of Changsha, Changsha, Hunan 410005, P.R. China
Published online on: May 16, 2019 https://doi.org/10.3892/etm.2019.7587
Pages: 523-530
Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Clinical characteristics and the cerebro-spinal fluid (CSF) cytokine changes in acquired immunodeficiency syndrome (AIDS) patients with tuberculous meningitis and cryptococcal meningitis in central nervous system (CNS) infections before and after treatment were investigated. The clinical records of 80 AIDS patients with CNS infections and 40 non-CNS infection patients hospitalized in the Infection Department of the First Hospital of Changsha from February 2013 to March 2016 were retrospectively analyzed. Forty-one cases of AIDS complicated with tuberculous meningitis were enrolled as group A, 39 cases of AIDS complicated with cryptococcal meningitis as group B, and 40 cases of non-CNS infection with lumbar puncture indication as group C. The general data, clinical symptoms, CSF examination and prognosis of the three groups of patients were collected. Of the 80 patients, 56 patients were discharged from hospital (improvement group) and 24 died (death group) after treatment. The concentrations of interferon-γ (IFN‑γ), interleukin-6 (IL-6), interleukin-10 (IL-10) and tumor necrosis factor-α (TNF-α) in CSF were detected by enzyme‑linked immunosorbent assay. There were significant differences in clinical manifestations, CSF pressure, CSF leucocyte count, CSF glucose, CSF chloride and CSF protein between group A, group B and group C (P<0.05). The concentrations of IFN-γ, IL-6, IL-10 and TNF-α in CSF of group A and group B increased significantly compared with group C (P<0.001). The IL-6, IL-10 and TNF-α levels in CSF in the improvement group were significantly lower than those in the death group (P<0.001), while the concentration of IFN-γ increased significantly (P<0.001). CSF biochemistry is characterized by increased pressure, leucocyte count and protein, and decreased chloride and glucose. IFN-γ, IL-6, IL-10 and TNF-α in CSF have certain predictive value for poor prognosis of AIDS patients with CNS infection.

View Figures

View References

1	Priya D, Sudharshan S and Biswas J: Management of a rare presentation of Vogt-Koyanagi-Harada disease in human immunodeficiency virus/acquired immunodeficiency disease syndrome patient. Indian J Ophthalmol. 65:413–416. 2017. View Article : Google Scholar : PubMed/NCBI
2	Moon S, Van Leemput L, Durier N, Jambert E, Dahmane A, Jie Y, Wu G, Philips M, Hu Y and Saranchuk P: Out-of-pocket costs of AIDS care in China: Are free antiretroviral drugs enough? AIDS Care. 20:984–994. 2008. View Article : Google Scholar : PubMed/NCBI
3	Zafer M, Horvath H, Mmeje O, van der Poel S, Semprini AE, Rutherford G and Brown J: Effectiveness of semen washing to prevent human immunodeficiency virus (HIV) transmission and assist pregnancy in HIV-discordant couples: A systematic review and meta-analysis. Fertil Steril. 105:645–655.e2. 2016. View Article : Google Scholar : PubMed/NCBI
4	Iroezindu MO, Agbaji OO, Daniyam CA, Isiguzo GC, Isichei C and Akanbi MO: Liver function test abnormalities in Nigerian patients with human immunodeficiency virus and hepatitis B virus co-infection. Int J STD AIDS. 24:461–467. 2013. View Article : Google Scholar : PubMed/NCBI
5	Swanson PA II and McGavern DB: Viral diseases of the central nervous system. Curr Opin Virol. 11:44–54. 2015. View Article : Google Scholar : PubMed/NCBI
6	Cordova E, Boschi A, Ambrosioni J, Cudos C and Corti M: Reactivation of Chagas disease with central nervous system involvement in HIV-infected patients in Argentina, 1992–2007. Int J Infect Dis. 12:587–592. 2008. View Article : Google Scholar : PubMed/NCBI
7	Aoki M, Hayashi H, Rao KV, Das D, Higashi-Kuwata N, Bulut H, Aoki-Ogata H, Takamatsu Y, Yedidi RS, Davis DA, et al: A novel central nervous system-penetrating protease inhibitor overcomes human immunodeficiency virus 1 resistance with unprecedented aM to pM potency. eLife. 6:62017. View Article : Google Scholar
8	Kugathasan R, Collier DA, Haddow LJ, El Bouzidi K, Edwards SG, Cartledge JD, Miller RF and Gupta RK: Diffuse white matter signal abnormalities on magnetic resonance imaging are associated with human immunodeficiency virus type 1 viral escape in the central nervous system among patients with neurological symptoms. Clin Infect Dis. 64:1059–1065. 2017. View Article : Google Scholar : PubMed/NCBI
9	Walker NF, Wilkinson KA, Meintjes G, Tezera LB, Goliath R, Peyper JM, Tadokera R, Opondo C, Coussens AK, Wilkinson RJ, et al: Matrix degradation in human immunodeficiency virus type 1-associated tuberculosis and tuberculosis immune reconstitution inflammatory syndrome: A prospective observational study. Clin Infect Dis. 65:121–132. 2017. View Article : Google Scholar : PubMed/NCBI
10	Torres RG, Etchebehere RM, Adad SJ, Micheletti AR, Ribeiro BM, Silva LE, Mora DJ, Paim KF and Silva-Vergara ML: Cryptococcosis in acquired immunodeficiency syndrome patients clinically confirmed and/or diagnosed at necropsy in a teaching hospital in Brazil. Am J Trop Med Hyg. 95:781–785. 2016. View Article : Google Scholar : PubMed/NCBI
11	Uldrick TS, Pipkin S, Scheer S and Hessol NA: Factors associated with survival among patients with AIDS-related primary central nervous system lymphoma. AIDS. 28:397–405. 2014. View Article : Google Scholar : PubMed/NCBI
12	Hoffmann C, Tabrizian S, Wolf E, Eggers C, Stoehr A, Plettenberg A, Buhk T, Stellbrink HJ, Horst HA, Jäger H, et al: Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery. AIDS. 15:2119–2127. 2001. View Article : Google Scholar : PubMed/NCBI
13	Hofer MJ and Campbell IL: Immunoinflammatory diseases of the central nervous system - the tale of two cytokines. Br J Pharmacol. 173:716–728. 2016. View Article : Google Scholar : PubMed/NCBI
14	Liao L, Xing H, Su B, Wang Z, Ruan Y, Wang X, Liu Z, Lu Y, Yang S, Zhao Q, et al: Impact of HIV drug resistance on virologic and immunologic failure and mortality in a cohort of patients on antiretroviral therapy in China. AIDS. 27:1815–1824. 2013. View Article : Google Scholar : PubMed/NCBI
15	Pollpeter D, Parsons M, Sobala AE, Coxhead S, Lang RD, Bruns AM, Papaioannou S, McDonnell JM, Apolonia L, et al: Deep sequencing of HIV-1 reverse transcripts reveals the multifaceted antiviral functions of APOBEC3G. Nat Microbiol. 3:220–233. 2018. View Article : Google Scholar : PubMed/NCBI
16	Coiras M, Bermejo M, Descours B, Mateos E, García-Pérez J, López-Huertas MR, Lederman MM, Benkirane M and Alcamí J: IL-7 induces SAMHD1 phosphorylation in CD4⁺ T lymphocytes, improving early steps of HIV-1 life cycle. Cell Rep. 14:2100–2107. 2016. View Article : Google Scholar : PubMed/NCBI
17	Sawai T, Nakao T, Koga S, Ide S, Yoshioka S, Matsuo N and Mukae H: Miliary tuberculosis with co-existing pulmonary cryptococcosis in non-HIV patient without underlying diseases: A case report. BMC Pulm Med. 18:62018. View Article : Google Scholar : PubMed/NCBI
18	Day CL, Abrahams DA, Harris LD, van Rooyen M, Stone L, de Kock M and Hanekom WA: HIV-1 infection is associated with depletion and functional impairment of mycobacterium tuberculosis-specific CD4 T cells in individuals with latent tuberculosis infection. J Immunol. 199:2069–2080. 2017. View Article : Google Scholar : PubMed/NCBI
19	He X, Shi X, Puthiyakunnon S, Zhang L, Zeng Q, Li Y, Boddu S, Qiu J, Lai Z, Ma C, et al: CD44-mediated monocyte transmigration across Cryptococcus neoformans-infected brain microvascular endothelial cells is enhanced by HIV-1 gp41-I90 ectodomain. J Biomed Sci. 23:282016. View Article : Google Scholar : PubMed/NCBI
20	Rahimy E, Li FY, Hagberg L, Fuchs D, Robertson K, Meyerhoff DJ, Zetterberg H, Price RW, Gisslén M and Spudich S: Blood-brain barrier disruption is initiated during primary HIV infection and not rapidly altered by antiretroviral therapy. J Infect Dis. 215:1132–1140. 2017. View Article : Google Scholar : PubMed/NCBI
21	Price RW, Peterson J, Fuchs D, Angel TE, Zetterberg H, Hagberg L, Spudich S, Smith RD, Jacobs JM, Brown JN, et al: Approach to cerebrospinal fluid (CSF) biomarker discovery and evaluation in HIV infection. J Neuroimmune Pharmacol. 8:1147–1158. 2013. View Article : Google Scholar : PubMed/NCBI
22	Graybill JR, Sobel J, Saag M, van Der Horst C, Powderly W, Cloud G, Riser L, Hamill R and Dismukes W; The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups, : Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. Clin Infect Dis. 30:47–54. 2000. View Article : Google Scholar : PubMed/NCBI
23	Umemura M, Okamoto-Yoshida Y, Yahagi A, Touyama S, Nakae S, Iwakura Y and Matsuzaki G: Involvement of IL-17A-producing TCR γδ T cells in late protective immunity against pulmonary Mycobacterium tuberculosis infection. Immun Inflamm Dis. 4:401–412. 2016. View Article : Google Scholar : PubMed/NCBI
24	Hogan LE, Vasquez J, Hobbs KS, Hanhauser E, Aguilar-Rodriguez B, Hussien R, Thanh C, Gibson EA, Carvidi AB, Smith LCB, et al: Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4⁺ T cells expressing CD30. PLoS Pathog. 14:e10068562018. View Article : Google Scholar : PubMed/NCBI
25	Akdis M, Aab A, Altunbulakli C, Azkur K, Costa RA, Crameri R, Duan S, Eiwegger T, Eljaszewicz A, Ferstl R, et al: Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases. J Allergy Clin Immunol. 138:984–1010. 2016. View Article : Google Scholar : PubMed/NCBI
26	Chakrabarti LA, Boucherie C, Bugault F, Cumont MC, Roussillon C, Breton G, Patey O, Chêne G, Richert L and Lortholary O; ANRS 129 BKVIR-CYTOK STUDY GROUP, : Biomarkers of CD4⁺ T-cell activation as risk factors for tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS. 28:1593–1602. 2014. View Article : Google Scholar : PubMed/NCBI
27	Kassa D, de Jager W, Gebremichael G, Alemayehu Y, Ran L, Fransen J, Wolday D, Messele T, Tegbaru B, Ottenhoff TH, et al: The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals. Tuberculosis (Edinb). 96:131–140. 2016. View Article : Google Scholar : PubMed/NCBI
28	Worsley CM, Suchard MS, Stevens WS, Van Rie A and Murdoch DM: Multi-analyte profiling of ten cytokines in South African HIV-infected patients with Immune Reconstitution Inflammatory Syndrome (IRIS). AIDS Res Ther. 7:362010. View Article : Google Scholar : PubMed/NCBI
29	Bulli L, Apolonia L, Kutzner J, Pollpeter D, Goujon C, Herold N, Schwarz SM, Giernat Y, Keppler OT, Malim MH, et al: Complex interplay between HIV-1 capsid and MX2-independent alpha interferon-induced antiviral factors. J Virol. 90:7469–7480. 2016. View Article : Google Scholar : PubMed/NCBI